Zevra Therapeutics (ZVRA) EPS (Basic) (2014 - 2026)
Zevra Therapeutics (ZVRA) reported EPS (Basic) of $0.62 for Q1 2026, up 1133.33% on a YoY basis from $0.05 in Q1 2025, and up 210.0% quarter-over-quarter from $0.2 in Q4 2025.
Zevra Therapeutics (ZVRA) EPS (Basic) (2014 - 2026) Analysis & Trends
Zevra Therapeutics has reported EPS (Basic) for 13 years, with the latest figure at $0.62 in Q1 2026.
- For the quarter ending Q1 2026, EPS (Basic) rose 1133.33% year-over-year to $0.62; the trailing twelve-month figure through Mar 2026 stood at $2.05 (up 206.77% YoY), and the FY2025 full-year result was $1.4, up 161.4% from the prior year.
- EPS (Basic) for Q1 2026 stood at $0.62, up from $0.2 in the prior quarter.
- The five-year high for EPS (Basic) was $1.24 in Q2 2025, with the low at -$0.69 in Q3 2024.
- Historically, EPS (Basic) has averaged -$0.14 across 5 years, with a median of -$0.3 in 2023.
- Annual changes were most pronounced in 2022 — EPS (Basic) slumped 620.0% — and 2026, when it jumped 1133.33%.
- Zevra Therapeutics' EPS (Basic) stood at -$0.09 in 2022, then slumped by 500.0% to -$0.54 in 2023, then dropped by 27.78% to -$0.69 in 2024, then soared by 128.99% to $0.2 in 2025, then jumped by 210.0% to $0.62 in 2026.
- The last three EPS (Basic) figures came in at $0.62 (Q1 2026), $0.2 (Q4 2025), and -$0.01 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | -0.68 |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 3.06 |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 0.00 |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | 0.00 |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | 0.00 |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | 0.00 |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 4.06 |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | -0.06 |
| 10 | Zevra Therapeutics | 704.96 Mn | 504.34 Mn | 34.30 Mn | 0.62 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.62 |
| Dec 31, 2025 | 0.20 |
| Sep 30, 2025 | -0.01 |
| Jun 30, 2025 | 1.24 |
| Mar 31, 2025 | -0.06 |
| Dec 31, 2024 | -0.69 |
| Sep 30, 2024 | -0.69 |
| Jun 30, 2024 | -0.48 |
| Mar 31, 2024 | -0.40 |
| Dec 31, 2023 | -0.54 |
| Sep 30, 2023 | -0.30 |
| Jun 30, 2023 | -0.08 |
| Mar 31, 2023 | -0.38 |
| Dec 31, 2022 | -0.09 |
| Sep 30, 2022 | -0.36 |
| Jun 30, 2022 | -0.64 |
| Mar 31, 2022 | 0.35 |
| Dec 31, 2021 | 0.05 |
| Sep 30, 2021 | -0.05 |
| Jun 30, 2021 | -0.40 |